Credit Suisse Ag Provention Bio, Inc. Transaction History

Credit Suisse Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$6.7 - $24.21 $831,764 - $3.01 Million	124,144 Added 138.29%	213,914 $5.16 Million
Q4 2022 Feb 13, 2023	BUY	$4.52 - $10.57 $244,500 - $571,763	54,093 Added 151.62%	89,770 $948,000
Q3 2022 Nov 10, 2022	BUY	$3.43 - $5.62 $1,186 - $1,944	346 Added 0.98%	35,677 $160,000
Q2 2022 Aug 12, 2022	SELL	$3.65 - $7.3 $6,383 - $12,767	-1,749 Reduced 4.72%	35,331 $140,000
Q1 2022 May 16, 2022	SELL	$3.4 - $7.88 $3,675 - $8,518	-1,081 Reduced 2.83%	37,080 $271,000
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $13,717 - $18,135	2,454 Added 6.87%	38,161 $214,000
Q3 2021 Nov 12, 2021	BUY	$5.66 - $8.33 $25,702 - $37,826	4,541 Added 14.57%	35,707 $227,000
Q2 2021 Aug 16, 2021	SELL	$6.71 - $11.04 $30,926 - $50,883	-4,609 Reduced 12.88%	31,166 $262,000
Q1 2021 May 14, 2021	SELL	$10.12 - $19.45 $119,810 - $230,268	-11,839 Reduced 24.86%	35,775 $375,000
Q4 2020 Feb 12, 2021	BUY	$11.79 - $18.94 $275,579 - $442,703	23,374 Added 96.43%	47,614 $807,000
Q3 2020 Nov 13, 2020	BUY	$10.34 - $15.2 $5,097 - $7,493	493 Added 2.08%	24,240 $311,000
Q2 2020 Aug 12, 2020	BUY	$7.81 - $17.0 $15,049 - $32,759	1,927 Added 8.83%	23,747 $335,000
Q1 2020 May 13, 2020	SELL	$5.42 - $17.75 $552,558 - $1.81 Million	-101,948 Reduced 82.37%	21,820 $200,000
Q4 2019 Feb 12, 2020	BUY	$5.84 - $14.9 $722,805 - $1.84 Million	123,768 New	123,768 $1.84 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.